UniProt/SwissProt ID: | EZH2_HUMAN |
Description: | enhancer of zeste homolog 2 (Drosophila) [Source:HGNC Symbol;Acc:3527] |
Location: | chr7 q36.1 |
Node attribute: | substrate |
Phosphorylation site |
Position | PhosphoPeptide | Catalytic kinase | Source |
---|---|---|---|
T421 | NSRCQtPIKMK | HPRD | |
S690 | FDYRYsQADAL | HPRD | |
S327 | NSSRPsTPTIN | HPRD | |
S8 | QTGKKsEKGPV | PhosphoSitePlus | |
S220 | PRKFPsDKIFE | PhosphoSitePlus | |
T300 | FAAALtAERIK | HPRD | |
Y696 | VNPNCyAKVMM | SET | PhosphoSitePlus |
T328 | SSRPStPTINV | HPRD | |
S405 | KKDETsSSSEA | PhosphoSitePlus | |
S413 | ETSSSsEANSR | HPRD | |
S369 | ETSSSsEANSR | HPRD | |
S375 | INVLEsKDTDS | PhosphoSitePlus | |
S363 | LPNNSsRPSTP | PhosphoSitePlus | |
T372 | SSRPStPTINV | HPRD | |
T487 | AEDVDtPPRKK | PhosphoSitePlus; phosphoELM; RegPhos; SysPTM | |
S371 | NSSRPsTPTIN | HPRD | |
S412 | SSEANsRCQTP | PhosphoSitePlus | |
S21 | RKRVKsEYMRL | AKT1 | HPRD; RegPhos |
T339 | FAAALtAERIK | PhosphoSitePlus; phosphoELM | |
T345 | AERIKtPPKRP | PhosphoSitePlus | |
S366 | NSSRPsTPTIN | PhosphoSitePlus; phosphoELM | |
S385 | SKDTDsDREAG | HPRD | |
Y23 | RVKSEyMRLRQ | PhosphoSitePlus | |
S734 | FDYRYsQADAL | HPRD | |
T460 | ARLIGtKTCRQ | PhosphoSitePlus | |
T416 | NSRCQtPIKMK | PhosphoSitePlus | |
T369 | RPSTPtINVLE | PhosphoSitePlus | |
T377 | NSRCQtPIKMK | HPRD | |
S341 | SKDTDsDREAG | HPRD | |
S380 | SKDTDsDREAG | PhosphoSitePlus; phosphoELM; RegPhos | |
S417 | SSEANsRCQTP | HPRD | |
S21 | RKRVKsEYMRL | PhosphoSitePlus; phosphoELM; RegPhos | |
T344 | FAAALtAERIK | HPRD | |
T492 | AEDVDtPPRKK | HPRD | |
S362 | RLPNNsSRPST | PhosphoSitePlus | |
S373 | SSEANsRCQTP | HPRD | |
S406 | KDETSsSSEAN | PhosphoSitePlus | |
T448 | AEDVDtPPRKK | HPRD | |
T367 | SSRPStPTINV | PhosphoSitePlus; phosphoELM | |
Dephosphorylation site |
EZH2_HUMAN do not have dephosphorylation site. |
Mutation site |
Ensembl ID | Variation | Source | Cancer name | Pubmed |
---|---|---|---|---|
ENSP00000320147 | R566H | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | R207* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | L674V | COSMIC | Lymphoma | 20601954 |
ENSP00000320147 | R63* | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | Q328* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | A656V | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | I150T | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | N693I | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | P132S | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | H297R | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | S538L | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000320147 | R25* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | R684C | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | D677H | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | E317* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | E726V | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | Q553* | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | P636L | COSMIC | Lymphoma | 21275949 |
ENSP00000320147 | N675K | COSMIC | Lymphoma | 20601954 |
ENSP00000320147 | R288Q | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | V704L | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | G159R | COSMIC | Lymphoma | 21390130 |
ENSP00000320147 | Q62* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | Y646N | COSMIC | Skin Cancer | 21984974 |
ENSP00000320147 | Y244D | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | R561H | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | I713T | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | N640K | COSMIC | Lymphoma | 20081860 |
ENSP00000320147 | W60* | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | Y181C | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000320147 | C571Y | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | I264R | COSMIC | Head and Neck Cancer | 21798893 |
ENSP00000320147 | L252V | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | Q58* | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | K243Q | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | Y731D | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | A345T | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | D664A | COSMIC | Lymphoma | 21909114 |
ENSP00000320147 | R509G | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | C576W | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | N322S | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | F145S | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | R690H | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | D192N | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | G135R | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | A255T | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | E249K | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | Y733* | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | V679M | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | G660R | COSMIC | Lymphoma | 20601953 |
ENSP00000320147 | H694Y | COSMIC | Lymphoma | 20724984 |
ENSP00000320147 | T573I | COSMIC | Lymphoma | 21921040 |
ENSP00000320147 | L149Q | COSMIC | Lymphoma | 21921040 |
Differential expressed protein |
Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
---|---|---|---|---|---|---|
ENSP00000419856 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 21 hour) | cell line | Up | 1.6 | 15169874 |
Hyperphosphorylation site |
EZH2_HUMAN do not have hyperphosphorylation site. |
Direct Interaction Pair |
Source | Target | Relationship | Resource |
---|---|---|---|
AKT1_HUMAN | EZH2_HUMAN | kinase -> substrate | HPRD; RegPhos |
ZAGL2_HUMAN | EZH2_HUMAN | kinase -> substrate | RegPhos |
Function Annotation |
KEGG Pathway |
EZH2_HUMAN is not in KEGG pathway. |
Gene Ontology |
GO ID | GO_Term | Evidence | Ontology |
---|---|---|---|
GO:0000084 | S phase of mitotic cell cycle | IEA | biological_process |
GO:0045605 | negative regulation of epidermal cell differentiat | IEA | biological_process |
GO:0048387 | negative regulation of retinoic acid receptor sign | IMP | biological_process |
GO:0042054 | histone methyltransferase activity | IDA | molecular_function |
GO:0051154 | negative regulation of striated muscle cell differ | IEA | biological_process |
GO:0045120 | pronucleus | IEA | cellular_component |
GO:0018024 | histone-lysine N-methyltransferase activity | IEA | molecular_function |
GO:0016571 | histone methylation | IEA | biological_process |
GO:0005634 | nucleus | IEA | cellular_component |
GO:0005515 | protein binding | IPI | molecular_function |
GO:0034244 | negative regulation of transcription elongation fr | IEA | biological_process |
GO:0042054 | histone methyltransferase activity | IEA | molecular_function |
GO:0021695 | cerebellar cortex development | IEA | biological_process |
GO:0003677 | DNA binding | TAS | molecular_function |
GO:0043565 | sequence-specific DNA binding | IEA | molecular_function |
GO:0042127 | regulation of cell proliferation | IEA | biological_process |
GO:0035098 | ESC/E(Z) complex | IDA | cellular_component |
GO:0050767 | regulation of neurogenesis | IEA | biological_process |
GO:0006325 | chromatin organization | TAS | biological_process |
GO:0006355 | regulation of transcription, DNA-dependent | TAS | biological_process |
GO:0005515 | protein binding | IEA | molecular_function |
GO:0014013 | regulation of gliogenesis | IEA | biological_process |
GO:0070734 | histone H3-K27 methylation | IEA | biological_process |
GO:0045892 | negative regulation of transcription, DNA-dependen | IMP | biological_process |
GO:0035098 | ESC/E(Z) complex | IEA | cellular_component |
GO:0070314 | G1 to G0 transition | IEA | biological_process |
GO:0003682 | chromatin binding | IEA | molecular_function |
GO:0001047 | core promoter binding | IEA | molecular_function |
GO:0006351 | transcription, DNA-dependent | IEA | biological_process |
GO:0010468 | regulation of gene expression | IEA | biological_process |
GO:0001932 | regulation of protein phosphorylation | IEA | biological_process |